Human Spinal Oligodendrogenic Neural Progenitor Cells Enhance Pathophysiological Outcomes and Functional Recovery in...

Area of Science:

• Neuroscience
• Regenerative Medicine
• Stem Cell Biology

Background:

• Traumatic spinal cord injury (SCI) causes significant cell loss and lacks regenerative treatments.
• Current interventions do not restore lost neural cells, tracts, or circuits.
• Neural stem/progenitor cell (NPC) transplantation is promising but faces challenges with inconsistent differentiation and functional recovery.

Purpose of the Study:

• To generate human induced pluripotent stem cell-derived oligodendrogenically biased NPCs (hiPSC-oNPCs).
• To characterize hiPSC-oNPCs in vitro and in vivo in a rodent model of cervical SCI.
• To evaluate the therapeutic potential of hiPSC-oNPCs for promoting regeneration and functional recovery after cervical SCI.

Main Methods:

• Generation and in vitro characterization of hiPSC-oNPCs.
• Transplantation of hiPSC-oNPCs into a rodent model of cervical SCI.
• In vivo assessment of cell engraftment, migration, differentiation, tissue preservation, remyelination, and functional recovery.
• Evaluation of neuropathic pain and tumor formation post-transplantation.

Main Results:

• Transplanted hiPSC-oNPCs engrafted, migrated, and preferentially differentiated into oligodendrocytes.
• oNPC transplantation led to tissue preservation and reduced astrogliosis.
• Remyelination of spared tissue was observed.
• Improved forelimb grip strength, gait, and locomotor function were noted in transplanted rats.
• No exacerbation of neuropathic pain or tumor formation occurred.

Conclusions:

• hiPSC-oNPC transplantation demonstrates therapeutic potential for cervical SCI.
• The approach promotes significant histopathological improvements and functional recovery.
• Further research is warranted to optimize this cell-based therapy for clinical application.